Evaluation and comparison of models of metabolic syndrome using confirmatory factor analysis

European Journal of Epidemiology

Volumn 21, Issue 5, 2006, Pages 343-349

  Shah, Sonalee ^a   Novak, Suzanne ^a   Stapleton, Laura M ^b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

Author keywords

Confirmatory factor analysis; Metabolic syndrome

Indexed keywords

LIPID;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; COMPUTER PROGRAM; CONTROLLED STUDY; DATA ANALYSIS; FACTORIAL ANALYSIS; FEMALE; HUMAN; INFORMATION PROCESSING; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; METABOLIC SYNDROME X; OBESITY; PRINCIPAL COMPONENT ANALYSIS; RELIABILITY; STATISTICAL SIGNIFICANCE;

HUMANS; METABOLIC SYNDROME X; MODELS, BIOLOGICAL; PRINCIPAL COMPONENT ANALYSIS; RISK FACTORS;

EID: 33745894155     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-006-9004-2     Document Type: Article

References (29)

1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
2. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752.
3. Lakka HM, Laaksonen DF, Lakka TA, et al. The metabolic syndrome and total cardiovascular disease mortality in middle-aged men. JAMA 2002; 288: 2709-2716.
4. Mitka M. Does the metabolic syndrome really exist? JAMA 2005; 294: 2010-2013.
5. Reaven GM, Lerner R, Stern M, et al. Role of insulin in endogenous hypertriglyceridemia. J Clin Invest 1967; 46: 1756-1767.
6. Kahn R, Guse J, Ferrannini E, et al. The metabolic syndrome: time for a critical appraisal. Diabetes Care 2005; 28: 2289-2304.
7. Hanson RL, Imperatore G, Bennett PH, Knowler WC. Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes 2002; 51: 3120-3127.
8. Young TK, Chateau D, Zhang M. Factor analysis of ethnic variation in the metabolic (insulin resistance) syndrome in three Canadian populations. Am J Human Biol 2002; 14: 649-658.
9. Meigs JB. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 2000; 152: 908-911.
10. Lawlor DA, Ebrahim S, May M, Davey Smith G. (Mis)use of factor analysis in the study of insulin resistance syndrome. Am J Epidemiol 2004; 159: 1013-1018.
11. Shen BJ, Todaro JR, Niaura R, et al. Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. Am J Epidemiol 2003; 157: 701-711.
12. Shen BJ, Goldberg RB, LLabre MM, et al. Is the factor structure of the metabolic syndrome comparable between men and women and across three ethnic groups: The Miami Community Health Study. Ann Epidemiol. (in press). Available online October 27, 2005.
13. Novak S, Stapleton M, Litaker JR, Lawson KA. A confirmatory factor analysis evaluation of the coronary heart disease risk factors of metabolic syndrome with emphasis on the insulin resistance factor. Diabetes Obes Metab 2003; 5: 388-396.
14. Bentler PM. EQS Structural Equations Program Manual. Encino, CA: Multivariate Software, 1995.
15. Hanley AJ, Karter AJ, Festa A, et al. Factor analysis of metabolic syndrome using directly measured insulin sensitivity. The Insulin Resistance Atherosclerosis Study. Diabetes 2002; 51: 2642-2647.
16. Pacini G, Bergman RN. MINMOD: a computer program to calculate insulin sensitivity, pancreatic responsiveness from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 1986; 23: 113-122.
17. Kline RB. Principles and Practice of Structural Equation Modeling. New York: Guilford Press, 1998.
18. Olefsky JM, Krusynska YT. Insulin resistance. In: Porte D, Jr., Sherwin RS, Baron A (eds), Ellenberg & Rifkin's Diabetes Mellitus. (6th ed.). McGraw-Hill, New York, 2003: 367-400.
19. Moller DE, Kaufman KD. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 2005; 56: 45-62.
20. Bollen KA. Structural Equations with Latent Variables. New York, NY: John Wiley & Sons, 1989.
21. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Structural Equation Modeling: A Multidisciplinary J 1999; 6: 1-55.
22. Fornell C, Larcker DF. Evaluating structural equation models with unobservable variables and measurement error. J Marketing Res 1981; 18: 39-50.
23. Hair JF, Anderson RE, Tatham RL, et al. Multivariate Data Analysis. (4th ed.) New York: Macmillan Publishing Company, 1995.
24. Salmenniemi U, Ruotsalainen E, Pihlajamaki J, et al. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome. Circulation 2004; 110: 3824-3848.
25. Pladevall M, Singal B, William LK, et al. A single factor underlies the metabolic syndrome: a confirmatory factor analysis. Diabetes Care 2006; 29: 113-122.
26. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. World Health Org, Geneva, 1999.
27. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults.. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2488-2497.
28. Moller DE, Kaufman KD. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 2005; 56: 45-62.
29. Betteridge D. LDL heterogeneity: implications for atherogenicity in insulin resistance and NIDDM. Diabetologia 1997; 40: 149S-151S.